BP indicates blood pressure; DBP, diastolic blood pressure; GL, guideline; JNC, Joint National Committee; and SBP, systolic blood pressure. 6 Two studies have projected large reductions in ASCVD and all-cause death among US adults through the achieve- ment of the BP goals in the 2017 Hypertension Clinical In 1 study, it was estimated that 3 million ASCVD events could be averted over the next 10 years through achievement and maintenance of the 2017 ACC/AHA BP goals (systolic/diastolic BP <130/80 mmHg; <130 mmHg for adults 65 years of age with low ASCVD risk), as compared with maintaining current BP and treatment and control levels.20 Overall, 33% of all ASCVD events prevented would be in those initiating antihypertensive treatment, and 67% would be in those intensifying current antihypertensive treatment.20 Despite the evidence-based recommendations for lower BP goals (<130/80 mmHg) in the 2017 Hyperten- sion Clinical Practice Guidelines,4 existing quality mea- sures from the NCQA for controlling HBP (for hyperten- sive adults 18 59 years of age whose BP was <140/90 have not changed substantially over the past several years for various insured populations, including commercial, Medicaid, Medicare Fee for Service, and Re-examining both the targets and processes of managing HBP are thus warranted to help support the use of the latest evidence in optimizing the quality of care and outcomes for patients with HBP. 1.2. Disclosure of Relationships With Industry and Other Entities The Task Force makes every effort to avoid actual, poten- tial, or perceived conflicts of interest that could arise as a result of relationships with industry or other entities (RWI). Detailed information on the ACC/AHA policy on RWI can be found at http://www.acc.org/guidelines/about-guide- lines-and-clinical-documents/relationships-with-industry- policy. 